2017/03/30 - 2016 annual financial results and next development steps in 2017

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced its 2016 annual financial results.

Download Press Release